(NASDAQ: WVE) Wave Life Sciences's forecast annual revenue growth rate of 59.74% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.68%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.49%.
Wave Life Sciences's revenue in 2026 is $42,727,000.On average, 17 Wall Street analysts forecast WVE's revenue for 2026 to be $7,260,428,811, with the lowest WVE revenue forecast at $0, and the highest WVE revenue forecast at $16,801,754,645. On average, 16 Wall Street analysts forecast WVE's revenue for 2027 to be $15,967,973,453, with the lowest WVE revenue forecast at $1,871,630,753, and the highest WVE revenue forecast at $32,084,291,810.
In 2028, WVE is forecast to generate $34,802,693,346 in revenue, with the lowest revenue forecast at $2,836,437,392 and the highest revenue forecast at $78,869,412,978.